Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany

dc.contributor.author	Krumbholz, Markus
dc.date.accessioned	2021-06-11T10:41:32Z
dc.date.available	2021-06-11T10:41:32Z
dc.date.issued	2020
dc.identifier.issn	1872-6968
dc.identifier.uri	http://hdl.handle.net/10900/116271
dc.language.iso	en	en
dc.publisher	Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.clineuro.2020.106142
dc.subject.ddc	610	de_DE
dc.title	Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_01177
utue.publikation.seiten	; Article 106142	de_DE
utue.personen.roh	Rauer, Sebastian
utue.personen.roh	Hoshi, Muna-Miriam
utue.personen.roh	Pul, Refik
utue.personen.roh	Wahl, Mathias
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Haas, Judith
utue.personen.roh	Ellrichmann, Gisa
utue.personen.roh	Krumbholz, Markus
utue.personen.roh	Tackenberg, Bjoern
utue.personen.roh	Saum, Kai-Uwe
utue.personen.roh	Buck, Fabian
utue.personen.roh	Leemhuis, Jost
utue.personen.roh	Kretschmann, Anita
utue.personen.roh	Aktas, Orhan
dcterms.isPartOf.ZSTitelID	Clinical Neurology and Neurosurgery	de_DE
dcterms.isPartOf.ZS-Volume	197	de_DE
utue.fakultaet	04 Medizinische Fakultät

Files in this item

Files	Size	Format	View
There are no files associated with this item.